Maria A. Santucci
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis.
Journal: Hematological oncology
Published: October 25, 2019
Chibby 1: a new component of β-catenin-signaling in chronic myeloid leukemia.
Journal: Oncotarget
Published: March 31, 2017
FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage.
Journal: Journal of cellular biochemistry
Published: January 04, 2017
DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemia.
Journal: Journal of cellular biochemistry
Published: May 30, 2014
A calpain-cleaved fragment of β-catenin promotes BCRABL1+ cell survival evoked by autophagy induction in response to imatinib.
Journal: Cellular signalling
Published: March 20, 2014
BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia.
Journal: PloS one
Published: July 08, 2013
Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells.
Journal: Cellular signalling
Published: February 22, 2013
DNA hypermethylation promotes the low expression of pro-apoptotic BCL2L11 associated with BCR-ABL1 fusion gene of chronic myeloid leukaemia.
Journal: British journal of haematology
Published: August 29, 2012
Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia.
Journal: Journal of cellular biochemistry
Published: April 03, 2012
Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor.
Journal: Leukemia research
Published: December 02, 2011
Histone H3 covalent modifications driving response of BCR-ABL1+ cells sensitive and resistant to imatinib to Aurora kinase inhibitor MK-0457.
Journal: British journal of haematology
Published: November 23, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026